StrideBio: Gene therapy firm expands operations in RTP as headcount reaches 100
A gene therapy developer based in Research Triangle Park has expanded its operations as it prepares to move its programs into clinical trials.
Read full article »
StrideBio is a North Carolina-based biotechnology firm that develops and commercializes gene therapies for the treatment of CNS and cardiovascular disorders.
Read more